Vaccine Supply Considerations
Influenza Prevention and Control Recommendations
Published for the 2010-11 Influenza Season; Adapted for the 2012-13 Influenza Season
The annual supply of influenza vaccine and the timing of its distribution cannot be guaranteed in any year. Influenza vaccine distribution delays or vaccine shortages remain possible. One factor that affects production is the inherent critical time constraints in manufacturing the vaccine given the annual updating of the influenza vaccine strains. Multiple manufacturing and regulatory issues also might affect the production schedule.
If supplies of seasonal influenza vaccine are not adequate, vaccination should be carried out in accordance with local circumstances of supply and demand based on the judgment of state and local health officials and health-care providers. National guidance for tiered use of influenza vaccine during prolonged distribution delays or supply shortfalls will be based primarily on epidemiologic studies indicating that certain persons are at higher risk for influenza infection or influenza-related complications, as well as which vaccine formulations have limited supplies. When epidemiologic studies or other data that would guide tiered use are unavailable, persons previously demonstrated to be at higher risk for influenza or influenza-related complications should be among those targeted by immunization programs for receipt of limited supplies. Even if vaccine use is not restricted to certain persons known to be at higher risk for influenza complications, strategies employed by immunization programs and providers during periods of limited vaccine availability should emphasize outreach to persons at higher risk for influenza or influenza-related complications, or who are part of populations that have limited access to medical care. During shortages of trivalent inactivated influenza vaccine (TIV), live-attenuated influenza vaccine (LAIV) should be used preferentially when feasible for all healthy nonpregnant persons aged 2--49 years (including health care professionals) who desire or are recommended for vaccination to increase the availability of inactivated vaccine for persons at high risk.
Information about the vaccine supply for the 2012-13 season is available at Seasonal Influenza Vaccine – Total Doses Distributed.